Literature DB >> 26071635

Gageopeptins A and B, new inhibitors of zoospore motility of the phytopathogen Phytophthora capsici from a marine-derived bacterium Bacillus sp. 109GGC020.

Fakir Shahidullah Tareq1, Choudhury M Hasan2, Hyi-Seung Lee3, Yeon-Ju Lee3, Jong Seok Lee3, Musrat Zahan Surovy4, Md Tofazzal Islam4, Hee Jae Shin5.   

Abstract

The motility of zoospores is critical in the disease cycles of the peronosporomycetes that cause devastating diseases in plants, fishes, vertebrates, and microbes. In the course of screening for secondary metabolites regulating the motility of zoospores of Phytophthora capsici, we discovered two new inhibitors from the ethyl acetate extract of the fermentation broth of a marine-derived strain Bacillus sp. 109GGC020. The structures of these novel metabolites were elucidated as new cyclic lipopeptides and named gageopeptins A (1) and B (2) by spectroscopic analyses including high resolution MS and extensive 1D and 2D NMR. The stereoconfigurations of 1 and 2 were assigned based on the chemical derivatization studies and reviews of the literature data. Although compounds 1 and 2 impaired the motility of zoospores of P. capsici in dose- and time-dependent manners, compound 1 (IC50 = 1 μg/ml) was an approximately 400-fold stronger motility inhibitor than 2 (IC50 = 400 μg/ml). Interestingly, the zoospores halted by compound 1 were subsequently lysed at higher concentrations (IC50 = 50 μg/ml). Compounds 1 and 2 were also tested against some bacteria and fungi by broth dilution assay, and exhibited moderate antibacterial and good antifungal activities.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lytic acitivity; Marine bacteria; Phytopathogens; Phytophthora capsici; Zoospore motility inhibitors

Mesh:

Substances:

Year:  2015        PMID: 26071635     DOI: 10.1016/j.bmcl.2015.05.070

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Marine Pharmacology in 2014-2015: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, Antiviral, and Anthelmintic Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Aimee J Guerrero; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Fumiaki Nakamura; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2019-12-19       Impact factor: 5.118

Review 2.  Screening of Marine Bioactive Antimicrobial Compounds for Plant Pathogens.

Authors:  Xiaohui Li; Hejing Zhao; Xiaolin Chen
Journal:  Mar Drugs       Date:  2021-01-28       Impact factor: 5.118

3.  Anti-Mycoplasma Activity of Bacilotetrins C-E, Cyclic Lipodepsipeptides from the Marine-Derived Bacillus subtilis and Structure Revision of Bacilotetrins A and B.

Authors:  Hwa-Sun Lee; Hee Jae Shin
Journal:  Mar Drugs       Date:  2021-09-22       Impact factor: 5.118

Review 4.  Secondary Metabolites from Marine-Derived Bacillus: A Comprehensive Review of Origins, Structures, and Bioactivities.

Authors:  Shaoyujia Xiao; Nan Chen; Zixue Chai; Mengdie Zhou; Chenghaotian Xiao; Shiqin Zhao; Xiliang Yang
Journal:  Mar Drugs       Date:  2022-09-06       Impact factor: 6.085

5.  Diversity and antimicrobial potential in sea anemone and holothurian microbiomes.

Authors:  Elizabeth León-Palmero; Vanessa Joglar; Pedro A Álvarez; Antonio Martín-Platero; Inmaculada Llamas; Isabel Reche
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.